Halo substituted aminotetralins

Details Halo substituted aminotetralins Halo substituted aminotetralins

1991-07-08

1993-07-06

Raymond, Richard L.

Organic compounds -- part of the class 532-570 series

Organic compounds

Amino nitrogen containing

564374, 549 79, C07C21700, C07C21774, C07C21100, C07C21160

Patent

active

052255964

ABSTRACT:
This invention is therapeutically useful tetralins and pharmaceutically acceptable acid addition salts thereof of the formula ##STR1## wherein X.sub.1 is halogen, CF.sub.3, --OR.sub.3, or --SR.sub.4 ; wherein R.sub.3 is alkyl(C.sub.1 -C.sub.8); alkenyl(C.sub.1 -C.sub.8); --CH.sub.2 -cycloalkyl(C.sub.3 -C.sub.8) or benzyl; wherein R.sub.4 is alkyl(C.sub.1 -C.sub.3); wherein X.sub.2 is hydrogen, CF.sub.3 or halogen; wherein R.sub.7 is hydrogen or methyl; wherein R.sub.1 is hydrogen, alkyl(C.sub.1 -C.sub.3), or cyclopropylmethyl; wherein R.sub.2 is --CH.sub.2 -cycloalkyl(C.sub.3 -C.sub.8), alkyl(C.sub.1 -C.sub.8), --(CH.sub.2).sub.q --R.sub.5 or --CH.sub.2 CH.sub.2 --Z--(CH.sub.2).sub.r CH.sub.3 ; wherein R.sub.5 is phenyl, 2-thiophene or 3-thiophene; wherein Z is oxygen or sulfur; and wherein p is one or 2, q is 2 or 3, and r is zero to 3; with the provisos that (1) when X.sub.1 is --OR.sub.3, X.sub.2 is halogen or CF.sub.3 ; and (2) when X.sub.1 is halogen, X.sub.2 is hydrogen, and p is 2, X.sub.1 is in a position other than the 8-position. These compounds are useful to treat central nervous system disorders.

REFERENCES:
patent: 4192888 (1980-03-01), Bondinell et al.
patent: 4788130 (1988-11-01), Oshiro et al.
Weinstock et al, J. Med. Chem., vol. 29 (1986) pp. 1615-1627.
DeMarinis et al, Chemical Abstracts, vol. 96 (1982) 51940w.
Hieble et al, Chemical Abstracts, vol. 97 (1982) 16659k.
Holz et al, Chemical Abstracts, vol. 98 (1983) 11098a.
Singh et al, Chemical Abstracts, vol. 100 (1984) 79479c.
Canon et al, J. Med. Chem., vol. 25 (1982) pp. 1442-1446.
Arvidsson et al, J. Med. Chem. vol. 27 (1984) pp. 45-51.
Ames, D. E., et al., J. Chem. Soc. 2636 (1965).
Arvidsson, L. E., et al., J. Med. Chem. 24, 921-923 (1981).
Arvidsson, L. E., J. Med. Chem. 30, 2105-2109 (1987).
Canon, J. G., et al., J. Med. Chem. 28, 515-518 (1985).
Dren, A. T., et al., J. Pharm. Sci. 67, 880-882 (1978).
McDermed, J. D., et al., J. Med. Chem. 18, 361-367 (1975).
McDermed, J. D., et al., J. Med. Chem. 19, 547-549 (1976).
Rusterholz, D. B., et al., J. Med. Chem. 19, 99-102 (1976).
Seeman, P., et al., Molecular Pharmacology 28, 291-299 (1985).
Wikstrom, H., et al., J. Med. Chem. 30, 1115 (1987).

Affiliated with

Also associated with

Rating

Halo substituted aminotetralins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Halo substituted aminotetralins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Halo substituted aminotetralins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1691220